The antibacterial effect of normal and infected urinary bladder.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000917:Antibody Formation; D000918:Antibody Specificity; D001437:Bacteriuria / Q000188:drug therapy; D002848:Chromatography, DEAE-Cellulose; D002908:Chronic Disease; D003556:Cystitis / Q000276:immunology*; D004927:Escherichia coli Infections / Q000276:immunology*; D007074:Immunoglobulin G / Q000096:biosynthesis; D007136:Immunoglobulins / Q000096:biosynthesis; D066298:In Vitro Techniques; D008297:Male; D010759:Phosphorus Isotopes; D014176:Protein Biosynthesis; D011512:Proteus Infections / Q000276:immunology*; D011817:Rabbits; D001743:Urinary Bladder / Q000276:immunology* / Q000378:metabolism; D014552:Urinary Tract Infections
D000900:Anti-Bacterial Agents; D007074:Immunoglobulin G; D007136:Immunoglobulins; D010759:Phosphorus Isotopes